Quality of life three years after diagnosis of localised prostate cancer: population based cohort study.
about
Low-dose rate brachytherapy for men with localized prostate cancerSocioeconomic status and health-related quality of life among patients with prostate cancer 6 months after radical prostatectomy: a longitudinal analysisDevelopment of South Australian-Victorian Prostate Cancer Health Outcomes Research Dataset.Cost-effectiveness of prostate cancer screening: a simulation study based on ERSPC data.PROSPECTIV-a pilot trial of a nurse-led psychoeducational intervention delivered in primary care to prostate cancer survivors: study protocol for a randomised controlled trialClinician-led improvement in cancer care (CLICC)--testing a multifaceted implementation strategy to increase evidence-based prostate cancer care: phased randomised controlled trial--study protocolProstate cancer outcomes in France: treatments, adverse effects and two-year mortalityValidity of using multiple imputation for "unknown" stage at diagnosis in population-based cancer registry data.Living with prostate cancer: randomised controlled trial of a multimodal supportive care intervention for men with prostate cancer.Focal laser interstitial thermotherapy (LITT) at 980 nm for prostate cancer: treatment feasibility in Dunning R3327-AT2 rat prostate tumour.The struggle towards 'the New Normal': a qualitative insight into psychosexual adjustment to prostate cancer.Using linked routinely collected health data to describe prostate cancer treatment in New South Wales, Australia: a validation studyA multicomponent theory-based intervention improves uptake of pelvic floor muscle training before radical prostatectomy: a 'before and after' cohort study.Quality-of-life effects of prostate-specific antigen screening.Relationship between lifestyle and health factors and severe lower urinary tract symptoms (LUTS) in 106,435 middle-aged and older Australian men: population-based study.Implementation and scientific evaluation of rehabilitative sports groups for prostate cancer patients: study protocol of the ProRehab StudyRecommendations on screening for prostate cancer with the prostate-specific antigen test.Evidence-based guideline recommendations on low-dose rate brachytherapy in patients with low- or intermediate-risk prostate cancer.The validity of the distress thermometer in prostate cancer populations.Systematic review: anal and rectal changes after radiotherapy for prostate cancer.Low-dose rate brachytherapy for patients with low- or intermediate-risk prostate cancer: A systematic review.Defining young in the context of prostate cancer.Establishing a population-based patient-reported outcomes study (PROMs) using national cancer registries across two jurisdictions: the Prostate Cancer Treatment, your experience (PiCTure) study.Prostate cancer mortality outcomes and patterns of primary treatment for Aboriginal men in New South Wales, Australia.Is prostate cancer screening cost-effective? A microsimulation model of prostate-specific antigen-based screening for British Columbia, CanadaAn update on the changing indications for androgen deprivation therapy for prostate cancer.The COMPASs Study: Community Preferences for Prostate cAncer Screening. Protocol for a quantitative preference study.Clinical intervals and diagnostic characteristics in a cohort of prostate cancer patients in Spain: a multicentre observational study.A pilot randomised controlled trial of personalised care after treatment for prostate cancer (TOPCAT-P): nurse-led holistic-needs assessment and individualised psychoeducational intervention: study protocolProspective quality-of-life outcomes for low-risk prostate cancer: Active surveillance versus radical prostatectomy.Survival gains needed to offset persistent adverse treatment effects in localised prostate cancerSmall but significant socioeconomic inequalities in axillary staging and treatment of breast cancer in the NetherlandsA retrospective analysis of Victorian and South Australian clinical registries for prostate cancer: trends in clinical presentation and management of the disease.Nurse-led group consultation intervention reduces depressive symptoms in men with localised prostate cancer: a cluster randomised controlled trial.Distress, delay of gratification and preference for palliative care in men with prostate cancer.Phase of care prevalence for prostate cancer in New South Wales, Australia: A population-based modelling studyEffects of a clinician referral and exercise program for men who have completed active treatment for prostate cancer: A multicenter cluster randomized controlled trial (ENGAGE)Australian patterns of prostate cancer care: Are they evolving?A cluster-randomised, parallel group, controlled intervention study of genetic prostate cancer risk assessment and use of PSA tests in general practice--the ProCaRis study: study protocolToward ethically responsible choice architecture in prostate cancer treatment decision-making.
P2860
Q24235544-25F3862E-CAB0-4BC1-8177-01B2DC95E1D6Q24658522-1A73EBA6-E1B2-4062-A41E-072A5F15C20CQ30361302-60581378-EE35-4E8D-9AF3-EEBA2065EE0BQ30878080-2DB68A8C-4286-497A-8AF0-5C1AC0912C84Q33691464-504A0B93-C364-4262-AACA-D8769EC91704Q33722746-2D7A5323-0508-4656-A4AD-64E8E80C8A30Q33795089-F3B3778E-3B18-4B06-AD3C-DB4C19501D39Q33842354-1810B475-0CB9-4EF6-A8A9-B3FB3BF77AB9Q33972182-D7390A2F-A9CD-4B55-B61B-41AE0A2033EDQ34012228-F976846A-3A8A-49AE-BF62-8DD31CE020CEQ34013452-1D5B8E25-C6BC-4EA4-8261-45D03F2F3283Q34041834-64AA28C6-3E05-4813-8197-7B0BAD6C43AEQ34140025-74FF4A16-FAD9-4066-AE28-D6F1E1A8B9CBQ34294102-D2D64227-446E-442D-94FF-7E2B05AD0938Q34343445-9D3CBB1B-2F3E-472B-8C4D-FA362556DFD0Q34350120-B2A7C1AA-57B0-4D6F-BC0F-4ACB0BFDADF1Q34435885-098E3F22-664B-4FA9-96AF-E93396929AB2Q34795596-D38D4D61-D698-4AB2-A9ED-B1CD1BF6C0FBQ34807091-9D5F3E79-ADD2-40FE-93D6-9455E79A68B8Q35024218-8A3717D4-C8EF-4FF4-8816-B5B1DEE7D611Q35079338-5D6B2006-9855-41F1-BD65-7803D53B32E0Q35181814-C83B389A-DCE0-4788-A8E9-2F51CB9DB9BEQ35466577-67DA0D6B-C2E1-49B0-B246-C44C61440ACCQ35535819-505284D1-A009-4C8E-9EFB-5E9649EBCC07Q35541638-538B1816-03DC-4CB7-904F-87B4056FE55FQ35549863-9C8E19CA-91A5-43D1-BF8E-14DC982855B9Q35659835-4FFF9C63-8593-4581-88A3-1931680E9F39Q35680616-B77C5EEC-E134-4F4C-A236-CF27C0D2FE34Q35803168-1B68767B-B227-4505-A9D9-AF4DFFFA93B4Q35812145-13AA7520-E199-4509-A0FD-D04A8AFDDE1CQ35883123-9DD2D15A-4D67-4E9F-8CB9-17FEB0BBFFE7Q36075221-F4439900-868B-4E2F-BA39-6A3E4823925BQ36096487-123EDB69-BF4C-4A9A-908B-CB578A29D4B0Q36105114-BB3C3722-AD26-4463-B106-9BE6061DD061Q36200494-64C06FB7-54E7-4DF2-8326-9E6406BFF991Q36274021-E066BC08-2440-41C0-A009-27AF6441D83BQ36302706-173F999E-C8E8-4AA2-B45C-C551CA1ED42FQ36680640-17C35B21-5D5B-42D7-A99A-9BA18BD78B38Q36730143-384D044F-45D7-407F-A4B5-FA17B32E4257Q36779782-7C1DF040-7450-4071-A74F-02F91D0428F9
P2860
Quality of life three years after diagnosis of localised prostate cancer: population based cohort study.
description
2009 nî lūn-bûn
@nan
2009年の論文
@ja
2009年学术文章
@wuu
2009年学术文章
@zh-cn
2009年学术文章
@zh-hans
2009年学术文章
@zh-my
2009年学术文章
@zh-sg
2009年學術文章
@yue
2009年學術文章
@zh
2009年學術文章
@zh-hant
name
Quality of life three years af ...... population based cohort study.
@en
Quality of life three years af ...... population based cohort study.
@nl
type
label
Quality of life three years af ...... population based cohort study.
@en
Quality of life three years af ...... population based cohort study.
@nl
prefLabel
Quality of life three years af ...... population based cohort study.
@en
Quality of life three years af ...... population based cohort study.
@nl
P2093
P2860
P356
P1433
P1476
Quality of life three years af ...... population based cohort study.
@en
P2093
Bruce K Armstrong
David P Smith
Dianne L O'Connell
Jeanette Ward
Madeleine T King
Martin P Berry
Paul Cozzi
P2860
P356
10.1136/BMJ.B4817
P407
P577
2009-11-27T00:00:00Z